Whatever you choose to call it - and our outgoing President was quite proud of the moniker "Obamacare", right up until the moment the tipping point had been reached - the following encapsulates the problem:
"It has not worked. In fact Obamacare has been a spectacular failure. Rather than providing affordable health care for all, it has been exposed at its core as a scheme which has indentured the entire populace to a system which is rigged to pick their pockets on a scale which is difficult to imagine unless one has actually seen it at work."
So, I'm very happy to go back on topic, but understand this: The outgoing administration of which you are so fond GAJ, put a gun to our heads while big government, big pharma, and big insurance looted and pillaged the bank accounts of already hard pressed Americans.
The world press being what it is, I'm not sure you fully grasp the extent to which the US election was a complete rejection and repudiation of the above described practices and policies. In fact, in reading your 'rebuttal', it is quite clear you do not.
No doubt big pharma will continue to fight tooth and nail for their obscene margins, but for Generic DAAs, the train has left the station. That ship has sailed. We know it, Gilead knows it, and increasingly the entire world knows it.
If they [Gilead] are successful in quashing the Indian supply chain, we will simply source medications elsewhere. Bangladesh for example, or Vietnam, or any one of a hundred other countries where licensing laws are non-applicable.
Dr. Freeman has been very active in blazing that trail, which one can already foresee will eventually become a super highway for access to lifesaving medications.
The world wide market is simply too large and compelling, and the need so overwhelming, that supply will inevitably seek out demand - no matter what artificial barriers are imposed.
Need proof the writing is on the wall? Gilead is already distancing itself from reliance on HCV medication cash flow, and looking elsewhere to source its cash 'pipelines'.
Preferring a 'captive' market, they [Gilead] have now set their sights on buying up proprietary cancer drugs (their greed and evil obviously knows no bounds) .
www.biospace.com/News/gilead-ceo-targets...tions-with-21/418644